UV Clinical A1 funding in the news!
At UV Clinical we are happy to announce that we have just closed our A1 funding round as planned. News of our capital raise has
03/23/2023
Menu
At UV Clinical we are happy to announce that we have just closed our A1 funding round as planned. News of our capital raise has
Today it is our privilege to announce that Emilio de la Guardia has joined UV Clinical as an investor and as a member of the Board of
We are delighted to announce that Peter Mørch Eriksen and Marie-Louise Struckmann have accepted our invitation to join the Advisory Board of UV Clinical. Both â€heavyweight†med-tech experts, Peter and
At UV Clinical our purpose is to save patients’ lives in the healthcare sector, and we are therefore pleased to announce that Søren Ulstrup has joined UV
It is well-known from in-vitro experiments and analysis of catheters and endotracheal tubes (ET tubes) removed from patients, such as, that microorganisms settle on surfaces and form a biofilm within 24 hours.
In order to further develop our UVC disinfection technology to an approved product UV clinical hasentered into a cooperation agreement with Technolution A/S. Technolution is
We have asked healthcare professionals about the problem and the relevance of our product. Read Lise Ekholdt’s, MD, comments here
The germicidal power of UVC light against coronavirus
UV Clinical receives funding through Keystones, a Danish Business Angels Network
UV Clinical receives funding from the Danish Innobooster program